Current Stroke Patients News and Events | Page 25

Current Stroke Patients News and Events, Stroke Patients News Articles.
Sort By: Most Relevant | Most Viewed
Page 25 of 25 | 1000 Results
Smartphone apps launched for atrial fibrillation patients and their healthcare providers
Novel smartphone and tablet applications (apps) for atrial fibrillation patients and healthcare professionals have been launched by heart experts. The objectives and design of the apps are outlined in a paper published online today in EP Europace,1 with a summary published in the European Heart Journal.2 (2017-10-10)

Safe to treat dementia patients with clot-busting drugs
Stroke patients with dementia treated with intravenous thrombolysis using powerful clot-busting drugs are at no higher risk of brain haemorrhage or death than other patients receiving the same treatment, a study from Karolinska Institutet published in the journal Neurology reports. (2017-10-09)

Meditation might be useful addition to heart-healthy lifestyle and medical treatment
Traditional medical therapy for high cholesterol, blood pressure and other risk factors remains the mainstay of preventing heart disease, but meditation may be helpful to some people who want to reduce the risk of heart disease as long as they understand its benefits have not been clearly established. (2017-09-28)

New class of molecules may protect brain from stroke, neurodegenerative diseases
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of molecules in the brain that synchronize cell-to-cell communication and neuroinflammation/immune activity in response to injury or diseases. Elovanoids (ELVs) are bioactive chemical messengers made from omega-3 very long chain polyunsaturated fatty acids (VLC-PUFAs,n-3). They are released on demand when cells are damaged or stressed. (2017-09-27)

The rat race is over: New livestock model for stroke could speed discovery
Researchers at the University of Georgia's Regenerative Bioscience Center have developed the first US pig model for stroke treatments. (2017-09-25)

Immune cells may heal bleeding brain after strokes
By studying rodents, researchers showed that instead of attacking germs, some neutrophils may help heal the brain after an intracerebral hemorrhage, a form of stroke caused by ruptured blood vessels. The study suggests that two neutrophil-related proteins may play critical roles in protecting the brain from stroke-induced damage and could be used as treatments for intracerebral hemorrhage. (2017-09-20)

New treatment for osteoporosis provides better protection against fractures
A new treatment for osteoporosis provides major improvements in bone density and more effective protection against fractures than the current standard treatment. These are the findings of a study published in the New England Journal of Medicine (NEJM). The study is the first that compares the effect of two osteoporosis medicines on fractures. (2017-09-19)

UTHealth discovers how to train damaging inflammatory cells to promote repair after stroke
Researchers at McGovern Medical School at UTHealth have discovered a way to turn neutrophils from toxic to helpful after a hemorrhagic stroke. (2017-09-19)

Blood pressure better controlled with 'MAP' for doctors
Primary care practices using the Measure accurately, Act rapidly and Partner with patients (MAP) program drove down hypertension rates among patients. In six months of MAP, hypertension control rose from 65.6 percent to 74.8 percent, among more than 21,000 hypertension patients at US primary care practices. (2017-09-16)

High blood pressure reasons differ by gender in teens; young adults
Gender matters when it comes to what's most likely to elevate blood pressure in young to middle-aged adults. The volume of blood pumped from the left ventricle during heartbeats, i.e., stroke volume, is the main determinant of blood pressure levels in women, while blood pressure in men is more likely to be determined by the amount of resistance in the body's blood vessels. (2017-09-15)

RESPECT trial shows closing a small hole in heart may protect against recurrent stroke
Extended follow-up demonstrates that a device used to close a small hole in the heart may benefit certain stroke patients by providing an extra layer of protection for those facing years of ongoing stroke risk. (2017-09-13)

Small study suggests twice-daily aspirin dosing could lead to more cardiovascular benefits for people with type 2 diabetes
Taking aspirin twice daily, rather than the current recommendation of once daily, could enhance cardiovascular protection in people with type 2 diabetes (T2D), suggests a small study being presented at this year's European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal. (2017-09-12)

Juvenile stroke: Causes often not known
Strokes without a definitive identifiable cause account for up to 50 percent of juvenile strokes. In juvenile strokes, the range of causes is wider and their frequency distribution differs from that in older stroke patients, in whom the classic cardiovascular risk factors are primarily implicated. (2017-09-08)

Study offers a new mindset in the search for stroke therapies
UNSW researchers have identified a promising new avenue to explore in the search for stroke treatments, after translating findings from Alzheimer's disease. (2017-09-07)

Some stroke survivors may have underlying cancer
Some stroke survivors may have underlying cancer, according to an observational study to be presented at the ESMO 2017 Congress in Madrid. (2017-09-06)

Determining motor deficits more precisely following a stroke
After a stroke, many people are unable to successfully perform basic hand movements in everyday life. The reason are symptoms of hemiparesis resulting from damage to the brain. These very frequently affect fine motor skills. A team from the Technical University of Munich is now paving the way to better diagnosis and more targeted therapy. (2017-09-06)

Not adhering to recommended exams for severe narrowing of the aortic valve associated with increased heart failure
Patients with asymptomatic severe aortic stenosis who did not follow recommended guidelines for regular exams had poorer survival and were more likely to be hospitalized for heart failure, according to a study published by JAMA Cardiology. (2017-09-06)

Drugs targeting the beta2-adrenoreceptor linked to Parkinson's disease
Researchers from Brigham and Women's Hospital want to prevent alpha-synuclein from accumulating in the brain. To do so, the team searched for drugs that turn down alpha-synuclein production. They then tested the drugs in mice and stem cells and studied in data from the health records of millions of people living in Norway. The results of their efforts, which point to a new drug development path for PD, are published in Science. (2017-08-31)

Stroke patient improvement with a brain-computer interface
Australian researchers have shown that it is possible for stroke patients to improve motor function using special training involving connecting brain signals with a computer. (2017-08-30)

Virus that causes mono may increase risk of MS for multiple races
Like whites, Hispanic and black people who have had mononucleosis, commonly known as mono, which is caused by Epstein-Barr virus, may have an increased risk of multiple sclerosis, according to a new study published in the Aug. 30, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology. (2017-08-30)

Electrocardiogram recording by patients boosts atrial fibrillation diagnosis (REHEARSE-AF)
Electrocardiogram (ECG) recording by patients with remote analysis by professionals identifies more atrial fibrillation (AF) than routine care, according to late-breaking results from a randomised trial presented today in a Hot Line -- LBCT Session at ESC Congress1 and published in Circulation. The approach has the potential to reduce AF-related strokes by starting preventative treatment earlier. (2017-08-29)

Anacetrapib reduces risk of serious cardiovascular events in high risk patients (REVEAL)
Anacetrapib, an inhibitor of cholesteryl ester transfer protein (CETP) activity, lowers the risk of heart attack and related cardiovascular complications in patients receiving intensive statin treatment, according to late-breaking results from the REVEAL trial presented today in a Hot Line Session at ESC Congress and published in the NEJM. (2017-08-29)

Rethinking dual antiplatelet guidelines in acute coronary syndrome? (CHANGE-DAPT)
New research presented at ESC Congress today1 suggests that for acute coronary syndrome (ACS) patients who require percutaneous coronary intervention (PCI), treatment according to contemporary guidelines for dual anti-platelet therapy (DAPT) could be less preferable than sticking to older guidelines. (2017-08-29)

Autoimmune diseases increase cardiovascular and mortality risk
Researchers from the Hospital del Mar Medical Research Institute (IMIM) and IDIAP Jordi Gol have just published an article showing that autoimmune diseases significantly increase cardiovascular risk as well as overall mortality. This is particularly pronounced in people suffering rheumatoid arthritis or systemic lupus erythematosus. In addition, it has been seen that inflammatory bowel diseases, such as Crohn's or ulcerative colitis, increase the risk of stroke and death through any cause. (2017-08-29)

Poor sleep is associated with ischemic heart disease and stroke
Poor sleep is associated with ischemic heart disease and stroke, according to research presented today at ESC Congress. The observational study in nearly 13,000 people revealed different patterns of sleep disturbance between the two conditions, with ischemic heart disease being linked to shorter sleep and brief moments of waking up. (2017-08-29)

Transcatheter aortic valve implantation safe and effective in nonagenarians
Transcatheter aortic valve implantation (TAVI) is safe and effective in nonagenarians, according to research presented at ESC Congress today.1 The observational study found that nonagenarians who underwent TAVI had worse short-term outcomes but similar one-year outcomes as patients younger than 90 years. (2017-08-28)

Education and feedback improve use of stroke prevention drugs in AF (IMPACT-AF)
Education of healthcare providers and patients with atrial fibrillation has led to a 9 percent absolute increase in the use of anticoagulation therapies to reduce stroke, according to late-breaking results from the IMPACT-AF trial presented today in a Hot Line LBCT Session at ESC Congress1 and published in the Lancet. (2017-08-28)

Apixaban lowers stroke risk in AF patients undergoing cardioversion (EMANATE)
Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to late-breaking results from the EMANATE trial presented today in a Hot Line LBCT Session at ESC Congress. Rates of bleeding were similar between the two groups. (2017-08-28)

Closure of left atrial appendage during heart surgery protects the brain (LAACS)
Closure of the left atrial appendage during heart surgery protects the brain, according to late-breaking research presented today in a Hot Line LBCT Session at ESC Congress.1 The results suggest that closure should be routinely added to open heart surgery. (2017-08-28)

PATHWAY-2 uncovers main cause of drug-resistant hypertension, finds old drugs work best
Salt retention is the main culprit behind drug-resistant hypertension (RHTN), with older diuretic medications being the most effective treatment, according to new results from the PATHWAY-2 study. (2017-08-28)

New analysis examines how low cholesterol can safely go (FOURIER)
Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively fewer cardiovascular events and appears to pose no safety concerns in patients with stable atherosclerotic cardiovascular disease over 2.2 years of follow-up, according to a new analysis of the FOURIER trial. (2017-08-28)

NIPPON follow-up: Shorter dual antiplatelet therapy stands the test of time (DAPT)
Three year follow-up of patients who received dual antiplatelet therapy (DAPT) after placement of a drug-eluting stent (DES) shows that a short course of the therapy continues to be as beneficial as a longer course. (2017-08-28)

Atrial fibrillation and blood pressure: More than just a number (AFFIRM)
New research presented at ESC Congress today shows, for the first time, that blood pressure control is pivotal in reducing major bleeding and stroke risk in patients with atrial fibrillation (AF). (2017-08-28)

Researchers find combination therapy works best for heart diseases
A major international study has found that the combination of two drugs -- rivaroxaban and aspirin -- is superior to aspirin alone in preventing further heart complications in people with vascular disease. The study of 27,400 people with stable coronary or peripheral artery disease from 33 countries worldwide shows that the combination of 2.5 mg of rivaroxaban twice daily plus 100 mg of aspirin once daily was significantly better than only aspirin or only rivaroxaban in preventing heart attacks, strokes and death. (2017-08-27)

When two is better than three: Dual antithrombotic therapy cuts bleeding risk
Clinical trial finds that dabigatran dual therapy after stenting reduced bleeding risk for patients with atrial fibrillation compared with standard triple therapy. (2017-08-27)

Rivaroxaban plus aspirin reduces adverse events (COMPASS)
Rivaroxaban plus aspirin reduces major adverse cardiovascular and limb events by nearly one-third in patients with peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line -- LBCT Session at ESC Congress. (2017-08-27)

Rivaroxaban plus aspirin improves outcomes in stable cardiovascular disease (COMPASS)
Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with stable coronary or peripheral artery disease, according to late-breaking results from the COMPASS trial presented today in a Hot Line - LBCT Session at ESC Congress1 and published in the NEJM. (2017-08-27)

Catheter ablation improves outcomes in patients with heart failure and AF (CASTLE-A)
Catheter ablation improves outcomes for patients with left ventricular dysfunction and atrial fibrillation, according to late-breaking results from the CASTLE-AF trial presented today in a Hot Line -- LBCT Session at ESC Congress.1 Patients who received catheter ablation of atrial fibrillation had lower mortality and less hospitalisation for worsening heart failure compared to those receiving conventional drug treatment. (2017-08-27)

ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases published today
European Society of Cardiology (ESC) Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, developed in collaboration with the European Society for Vascular Surgery (ESVS), are published online today in European Heart Journal,1 European Journal of Vascular and Endovascular Surgery, and the ESC website. (2017-08-26)

Implanted cardiac monitors indicate incidence of undiagnosed AFib may be substantial in high-risk patients
With the use of implanted cardiac monitors researchers found a substantial incidence (nearly 30 percent) of previously undiagnosed atrial fibrillation (AF) after 18 months in patients at high risk of both AF and stroke, according to a study published by JAMA Cardiology. The study is being released to coincide with its presentation at the European Society of Cardiology Congress 2017. (2017-08-26)

Page 25 of 25 | 1000 Results
   First   Previous   Next      Last is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to